MYND Diagnostics

MYND Diagnostics is a neuropharmaceutical development company based on life sciences, dedicated to developing drugs utilizing psychedelic compounds. Our mission is to advance our existing research and patents, linking depression and inflammation at the genetic and cellular levels to develop pharmaceutical treatments. MYND Diagnostics is a wholly-owned subsidiary of MYND Life Sciences.